GIM Research-in-Progress Seminar
Join us for this free, accredited educational activity, where three trainees in GIM will present an ongoing project and receive feedback from a panel of early career and senior researchers.
Research/QI Summit: GIM Research-in-Progress Seminar
Dr. Haris Akhtar, Dr. Marc-Alexandre Gingras and Dr. Jonathan Houle
March 4, 2021 – 4:00-5:15pm Eastern Time
- Formulate a comprehensive protocol for conducting research in General Internal Medicine from study design to statistical analysis plan.
- Select the appropriate methodology for conducting research and apply principles of research in epidemiology to your own studies.
- Identify and address hurdles for successfully completing research during your early career.
The live session Research/QI Summit: GIM Research-in-Progress Seminar is an educational activity approved as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. As an accredited provider, CSIM has approved this program for 1.25 credit hours.
- View faculty and planning committee conflict of interest disclosures.
- Physicians should only claim credit commensurate with the extent of their participation in the activities.
- Claim your MOC credits at the Royal College of Physicians and Surgeons of Canada Mainport site.
About the Panel Members
Dr. Kaberi Dasgupta
Kaberi Dasgupta is a Physician, Scientist, and Professor of Medicine at McGill University and the McGill University Health Centre. Her research focus is prevention, reversal, and self-management support in diabetes. Her research is funded by the CIHR, Heart & Stroke Foundation, Lawson Foundation, and Diabetes Canada. She has published over 120 papers and her research has received a high level of media coverage because of its direct relevance to patients, practitioners, and policy makers. She is the Director of the Centre for Ourcomes Research and Evaluation (CORE) at the Research Institute of the McGill University Health Centre.
Dr. Michael Fralick
Michael is a board-certified General Internist in Canada and the US. He completed his medical degree and internal medicine residency training at the University of Toronto. He then completed a Master’s of Science in Clinical Epidemiology at Harvard University including a research fellowship in Pharmacoepidemiology at the Division of Pharmacoepidemiology and Pharmacoeconomics. His PhD, completed at the University of Toronto, focused on the intersection between machine learning and pharmacoepidemiology. He works clinically at Mount Sinai Hospital in Toronto and The Sault Area Hospital in Sault Ste Marie.